164 related articles for article (PubMed ID: 20590033)
1. [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].
Ameri AA
MMW Fortschr Med; 2010 Jun; 152(22):42-3. PubMed ID: 20590033
[No Abstract] [Full Text] [Related]
2. [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
Krüger B; Held C; Kircheis G
Z Arztl Fortbild (Jena); 1994 Sep; 88(9):673-9. PubMed ID: 7975752
[No Abstract] [Full Text] [Related]
3. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
Chen MF; Li RC; Chen CH; Gao XC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
[TBL] [Abstract][Full Text] [Related]
5. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
[TBL] [Abstract][Full Text] [Related]
6. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
8. [In liver cirrhosis, not every "ammonia lowering drug" improves neuropsychiatric deficit].
MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288540
[No Abstract] [Full Text] [Related]
9. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
Ndraha S; Simadibrata M
Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
[TBL] [Abstract][Full Text] [Related]
10. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.
Ndraha S; Hasan I; Simadibrata M
Acta Med Indones; 2011 Jan; 43(1):18-22. PubMed ID: 21339541
[TBL] [Abstract][Full Text] [Related]
11. Minimal hepatic encephalopathy: time to recognise and treat.
Dhiman RK; Chawla YK
Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Utzt MJ
MMW Fortschr Med; 2015 Jun; 157 Suppl 2():54. PubMed ID: 26048124
[No Abstract] [Full Text] [Related]
13. [Pathogenesis, diagnosis and treatment of hepatic encephalopathies in patients with liver cirrhosis].
Moĭseienko VO; Manzhaliĭ EH; Solonovych OS; Nykula TD
Lik Sprava; 2014 Nov; (11):39-47. PubMed ID: 25528831
[TBL] [Abstract][Full Text] [Related]
14. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
[No Abstract] [Full Text] [Related]
15. [Because hepatic encephalopathy is a frequent contributing factor. Patients with liver cirrhosis are poorer drivers].
MMW Fortschr Med; 2003 Nov; 145(47):61. PubMed ID: 14725039
[No Abstract] [Full Text] [Related]
16. A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.
Soárez PC; Oliveira AC; Padovan J; Parise ER; Ferraz MB
Arq Gastroenterol; 2009; 46(3):241-7. PubMed ID: 19918694
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of hepatic encephalopathy with Hepa-Mertz].
Podymova SD; Bueverov AO; Nadinskaia MIu
Ter Arkh; 1995; 67(6):45-7. PubMed ID: 7667779
[TBL] [Abstract][Full Text] [Related]
18. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.
Jiang Q; Jiang XH; Zheng MH; Chen YP
J Gastroenterol Hepatol; 2009 Jan; 24(1):9-14. PubMed ID: 18823442
[TBL] [Abstract][Full Text] [Related]
19. [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035428
[No Abstract] [Full Text] [Related]
20. [HEPATIC ENCEPHALOPATHY AND TISSUE ZINC LEVELS IN LIVER DISEASE, DIAGNOSIS AND TREATMENT].
Plotnikova EY; Baranova EN; Maksimov SA
Eksp Klin Gastroenterol; 2015; (7):46-54. PubMed ID: 26817122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
